These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15172041)

  • 1. Overview of radiologic efficacy of new treatments.
    van der Heijde DM
    Rheum Dis Clin North Am; 2004 May; 30(2):285-93, vi. PubMed ID: 15172041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpreting radiographic data in rheumatoid arthritis.
    Ory PA
    Ann Rheum Dis; 2003 Jul; 62(7):597-604. PubMed ID: 12810418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drugs for rheumatoid arthritis.
    Olsen NJ; Stein CM
    N Engl J Med; 2004 May; 350(21):2167-79. PubMed ID: 15152062
    [No Abstract]   [Full Text] [Related]  

  • 5. "Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate.
    Hochberg MC; Tracy JK; Flores RH
    Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii51-4. PubMed ID: 11890654
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-cytokine therapy for connective tissue disease].
    Hayashi T; Goto D; Sumida T
    Nihon Rinsho; 2005 May; 63 Suppl 5():233-9. PubMed ID: 15954355
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in the medical management of rheumatoid arthritis.
    Scott DL
    Hosp Med; 2002 May; 63(5):294-7. PubMed ID: 12066349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tides of inflammation: impact of biologics.
    St Clair EW
    J Rheumatol Suppl; 2002 Sep; 65():22-6. PubMed ID: 12236618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of anakinra in bone: comparison to other biologics.
    Paget SA
    Adv Ther; 2002; 19(1):27-39. PubMed ID: 12008859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the efficacy of biologic therapy: are there real differences?
    Fleischmann RM
    J Rheumatol Suppl; 2002 Sep; 65():27-32. PubMed ID: 12236619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic use of "biologics" in inflammatory joint and spinal diseases].
    Seitz M
    Ther Umsch; 2002 Oct; 59(10):535-43. PubMed ID: 12428439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the treatment of rheumatoid arthritis.
    Strand V
    Clin Cornerstone; 1999; 2(2):38-50. PubMed ID: 10689543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of new biologicals in the treatment of rheumatoid arthritis.
    Weaver AL
    Rheumatology (Oxford); 2004 Jun; 43 Suppl 3():iii17-iii23. PubMed ID: 15150428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the treatment of rheumatoid arthritis.
    Pisetsky DS; St Clair EW
    JAMA; 2001 Dec; 286(22):2787-90. PubMed ID: 11735734
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological modifier therapy for the treatment of rheumatoid arthritis.
    Jenkins JK; Hardy KJ
    Am J Med Sci; 2002 Apr; 323(4):197-205. PubMed ID: 12003375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological agents for therapy of rheumatoid arthritis--overview].
    Takeuchi T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():513-6. PubMed ID: 15799409
    [No Abstract]   [Full Text] [Related]  

  • 17. New disease modifying agents in adult rheumatoid arthritis.
    Koh ET
    Ann Acad Med Singap; 2001 Mar; 30(2):170-3. PubMed ID: 11379415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study.
    Furst DE; Gaylis N; Bray V; Olech E; Yocum D; Ritter J; Weisman M; Wallace DJ; Crues J; Khanna D; Eckel G; Yeilding N; Callegari P; Visvanathan S; Rojas J; Hegedus R; George L; Mamun K; Gilmer K; Troum O
    Ann Rheum Dis; 2007 Jul; 66(7):893-9. PubMed ID: 17412737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha inhibitors, methotrexate or both? An inquiry into the formal evidence for when they are to be used in rheumatoid arthritis.
    Yazici Y; Yazici H
    Clin Exp Rheumatol; 2008; 26(3):449-52. PubMed ID: 18578967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New antirheumatic drugs: any real added value? A critical overview of regulatory criteria for their marketing approval.
    Bertele' V; Assisi A; Di Muzio V; Renzo D; Garattini S
    Eur J Clin Pharmacol; 2007 Sep; 63(9):879-89. PubMed ID: 17646975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.